Cumberland Pharmaceuticals Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
Cumberland Pharmaceuticals Inc. (CPIX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 36.10 thousand shares for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-07.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2025-03-07
- Cumberland Pharmaceuticals Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2011-12-31 was -339.72K shares.
- Cumberland Pharmaceuticals Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2011-09-30 was 152.34K shares.
- Cumberland Pharmaceuticals Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2024 was 36.10K shares, a 43.54% increase from fiscal 2023.
- Cumberland Pharmaceuticals Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2023 was 25.15K shares, a 15.89% decline from fiscal 2022.
- Cumberland Pharmaceuticals Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2022 was 29.90K shares.
- Cumberland Pharmaceuticals Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2020 was 0.00 shares, a 100.00% decline from fiscal 2019.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month |
|---|---|---|---|---|
| 2024-12-31 | 36.10K shares 10-K · filed 2025-03-07 | |||
| 2023-12-31 | 25.15K shares 10-K · filed 2025-03-07 | |||
| 2022-12-31 | 29.90K shares 10-K · filed 2024-03-13 | |||
| 2020-12-31 | 0.00 shares 10-K · filed 2021-03-12 | |||
| 2019-12-31 | 5.80K shares 10-K · filed 2021-03-12 | |||
| 2018-12-31 | 0.00 shares 8-K · filed 2020-12-10 | |||
| 2017-12-31 | 0.00 shares 10-K · filed 2019-03-12 | |||
| 2016-12-31 | 6.50K shares 10-K · filed 2018-03-09 | |||
| 2015-12-31 | 140.40K shares 10-K · filed 2017-03-13 | |||
| 2014-12-31 | 198.14K shares 10-K · filed 2016-03-14 | |||
| 2013-12-31 | 139.28K shares 10-K · filed 2015-03-09 | |||
| 2012-12-31 | 435.60K shares 10-K · filed 2014-03-11 | |||
| 2011-12-31 | -339.72K shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | -187.38K shares derived: sum of 2 quarters · filed 2013-03-12 | 125.90K shares 10-K · filed 2013-03-12 | |
| 2011-09-30 | 152.34K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | 465.62K shares 10-Q · filed 2011-11-07 | ||
| 2011-06-30 | 313.28K shares 10-Q · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |